Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke
Authors
Keywords
-
Journal
STROKE
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-02-17
DOI
10.1161/strokeaha.120.031197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
- (2020) Michael D Hill et al. LANCET
- Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
- (2019) Jie Xu et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Effect of Edaravone on Neurological Symptoms in Real-World Patients With Acute Ischemic Stroke
- (2019) Susumu Kobayashi et al. STROKE
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2019) William J. Powers et al. STROKE
- 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2018) William J. Powers et al. STROKE
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Mohsen Naghavi et al. LANCET
- Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial
- (2017) Jacob Elkins et al. LANCET NEUROLOGY
- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013
- (2016) Maigeng Zhou et al. LANCET
- Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation
- (2016) Ángel Chamorro et al. LANCET NEUROLOGY
- ALIAS (Albumin in Acute Ischemic Stroke) Trials
- (2016) Renee’ H. Martin et al. STROKE
- Middle cerebral artery remodeling following transient brain ischemia is linked to early postischemic hyperemia: A target of uric acid treatment
- (2015) Yara Onetti et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Prehospital Use of Magnesium Sulfate as Neuroprotection in Acute Stroke
- (2015) Jeffrey L. Saver et al. NEW ENGLAND JOURNAL OF MEDICINE
- The synergetic effect of edaravone and borneol in the rat model of ischemic stroke
- (2014) Hai-Yin Wu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial
- (2014) Ángel Chamorro et al. LANCET NEUROLOGY
- High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial
- (2013) Myron D Ginsberg et al. LANCET NEUROLOGY
- Borneol, a Bicyclic Monoterpene Alcohol, Reduces Nociceptive Behavior and Inflammatory Response in Mice
- (2013) Jackson Roberto Guedes da Silva Almeida et al. TheScientificWorldJOURNAL
- II. Cerebral Infarction/Transient Ischemic Attack (TIA)
- (2011) Yukito Shinohara et al. Journal of Stroke & Cerebrovascular Diseases
- A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?
- (2010) Paul A Lapchak EXPERT OPINION ON PHARMACOTHERAPY
- Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κappaB signaling pathway
- (2010) R. Liu et al. NEUROSCIENCE
- NXY-059 for the Treatment of Acute Stroke
- (2008) Hans-Christoph Diener et al. STROKE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started